Actively Recruiting
Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center
Led by Ohio State University · Updated on 2026-01-07
100
Participants Needed
1
Research Sites
190 weeks
Total Duration
On this page
Sponsors
O
Ohio State University
Lead Sponsor
S
Scientia Vascular, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the function of matched pair Aristotle 14 Guidewire and Plato Microcatheter in MMA embolization treatment for chronic subdural hematoma compared to surgeon's preference
CONDITIONS
Official Title
Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥ 18 years old
- Patient or legally authorized representative (LAR) signs an informed consent form
- Confirmed diagnosis of subacute or chronic subdural hematoma, defined as 50% or more chronic blood
- Pre-morbid Modified Rankin Score of ≤ 3
You will not qualify if you...
- Age < 18 years old
- Potentially dangerous anatomic variations leading to increased procedural risk or unsafe access for MMA embolization
- Unmanaged, uncontrolled bleeding disorders/blood diathesis
- Presumed septic embolus, or suspicion of microbial superinfection
- Contraindication to angiography
- CT or MRI evidence of intra-cranial tumor or mass lesion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States, 43210
Actively Recruiting
Research Team
E
Edouard Belizaire
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here